Navigation Links
Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results
Date:4/21/2008

CONFERENCE CALL AND WEBCAST SCHEDULED FOR WEDNESDAY, APRIL 30

SAN DIEGO, April 21 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its first quarter 2008 financial results after the Nasdaq market closes on Wednesday, April 30, 2008. Neurocrine will host a live conference call and webcast to discuss its financial results and provide a Company update Wednesday afternoon, April 30, 2008 at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

Participants can access the live conference call by dialing 1-800-895-1715 (US) or 785-424-1059 (International) using the conference ID: 7NBIX1. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com

If you are unable to attend the Webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 1-800-753-9146 (US) or 402-220-2705 (International) using the conference ID: 7NBIX1. The call will be archived for two weeks.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. The product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet a
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
2. Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
3. Neurocrine Announces Work Force Restructuring
4. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
5. Neurocrine Biosciences Announces Conference Call and Webcast to Provide Indiplon Update
6. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2007 Financial Results
8. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
9. Neurocrine Biosciences to Present at the A.G. Edwards Annual Emerging Growth Conference
10. Neurocrine Biosciences to Present at the Bear Stearns Healthcare Conference
11. Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...atu National Advisory Committee on Climate Change ...(SNC) Project in collaboration with the Vanuatu Me...Zealand have generated preliminary climate change ...ground for the country’s SNC reporting to th...hange (UNFCCC). , Port V...
(Date:11/26/2009)... generation of ultrasmall transistors and more pow...semiconducting nanowires are closer to reality aft...niversity and the University of California at Los ...reate nanowires with layers of different materials...ch is a critical requirement for making efficient ...
(Date:11/25/2009)..., BOCA RATON, Fla., Nov. 25 For ... so for BodyLogicMD. The nation,s largest and fas...zing exclusively in medically supervised bioident...ans in its network since November 2008 - from 2...re physician-owned centers, including one in Puert...
(Date:11/25/2009)...RNewswire-FirstCall/ -- Ardea Biosciences, Inc. (N..., Pharm.D., president and chief executive officer,...lth Care Conference. , ,Presentation details are ... Conference,Date: Tuesday, December 1, 2009,T...w York Palace Hotel, New York, NY,Webcast: <a h...
Breaking Biology Technology:Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
... Tutogen Medical, Inc.,(Amex: TTG ), a leading ma...made from human (allograft) and animal (xenograft)... fiscal year and fourth quarter ended September,30...cal year include:, -- Total fiscal year 2007 rev... increased 38% in fiscal year 2007; -- Sales of ...
...s next-generation sequencing with latest microarra...LBERG, Germany, and LA JOLLA, Calif., Dec. 10 ,Par...new Genome-to-Array,Service. This Service gives sc...how in sequencing and microarrays even for DNA whe...is service, scientists can go from,biological gene...
...olio of Technologies for Enabling Faster, Easier,Q...al Medicine and Adaptive ...ion Biomarkers Inc (DBI),a leading developer of pr...l research and development, today announced the co... States Patent 7,297,497 by the,U.S. Patent and Tr...
Other Biology Technology:Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 2Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 3Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 4Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 5Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 6Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 7Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 8Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 9Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 10New Microbial Genome-to-Array Service 2Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry 2
(Date:11/26/2009)...rried out in eight European countries has shown th...isease pandemic could have a significant role in r...in the open access journal BMC Infectious Disease...days and weekends/holidays, finding that they were...m Hasselt and Antwerp University, Belgium, led a t...
(Date:11/25/2009)...hormone produced in the stomach, may be used to bo...kinson,s disease, Yale School of Medicine research...of the Journal of Neuroscience . , Parkinson,s ...urons in an area of the midbrain known as the subs...oduction. Reduced production of dopamine in late-...
(Date:11/25/2009)...urse of a lifetime, the heart pumps some 250 milli...to do this, the muscle fibers of the heart have to...y Dr. Wolfgang Rottbauer, vice chair of the Depart...ital (Chairman: Prof. Dr. H. A. Katus), has discov...ty of the smallest muscular unit, the sarcomere. I...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Hormone ghrelin can boost resistance to Parkinson's disease 2New genetic cause of cardiac failure discovered 2CRH Medical introduces non surgical hemorroid removal to Gastroenterology Fellowship program 50312 1CRH Medical introduces non surgical hemorroid removal to Gastroenterology Fellowship program 50312 2No More Drama With TOMA LECHE 50310 1No More Drama With TOMA LECHE 50310 2No More Drama With TOMA LECHE 50310 3No More Drama With TOMA LECHE 50310 4Maybe Men Arent So Picky After All 50309 1Maybe Men Arent So Picky After All 50309 2
...As the specter of a worldwide outbreak of avian or...at new drugs are desperately needed since some str...e to the current roster of anti-flu remedies. , N...elp of resources at the San Diego Supercomputer Ce...more than two dozen promising and novel compounds ...
...esearchers at North Carolina State University have...e the skin if there is an abrasion, providing insi...re workers or individuals involved in the manufact...al biomedical applications of the tiny nanoparticl... different sizes, shapes and surface coatings do n...
...This release is available in German . , Metabolo...olecules of a cell or a tissue. The exponents of b...work of a pre-clinical metabolomics study in healt...the animals was treated with the diabetes drug Roz... quantitatively determined in a blood plasma sampl...
Other Biology News:UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 2UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 3UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 4Study shows quantum dots can penetrate skin through minor abrasions 2Healthy or diseased? 2
... a unique split septum design. Features 384 sp... plates (AB-0937, AB-1055, AB-1056) Suitable for ...wn hot lid thermal cyclers Pierceable with standa...rced simultaneously Less than 0.5N pierce pressu...
...rces for 8 vessels while occupying little lab spac...d electronically. Both, speed and flow set points,...led miniature pumps can be equipped with variable ...420 mL/h with the standard module. A more powerful...
Mitochondria Isolation Kit from Sigma-Aldrich
...rces for 4 vessels while occupying little lab spac...d electronically. Both, speed and flow set points,...led peristaltic pumps can be equipped with variabl... to 5 L/h with the standard module. The in built c...
Biology Products: